The TFs play a key role in SCLC heterogeneity and modulate disease progression; however, the targeting of these TFs is not successful as these modulators are also involved in physiological processes and no small molecule is available to target ASCL1, NEUROD1, or POU2F3. The gene discussed is ASCL1; the disease is small cell lung carcinoma.